Akums Drugs and Pharmaceuticals reported a 15% increase in adjusted profit after tax, reaching Rs 66.3 crore for the quarter ...
of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...
API EBITDA losses reduced significantly in Q3 YoY, although prices of cephalosporin APIs ... With our focus on establishing Akums' global CDMO footprint, we took a significant step by securing ...
New Delhi [India], February 8: Akums Drugs and Pharmaceuticals Ltd., has announced its consolidated financial results for the quarter ended December 31, 2024, delivering 12% increase in Adjusted ...
Akums Drugs and Pharmaceuticals Ltd., has announced its consolidated financial results for the quarter ended December 31, ...
Akums Drugs and Pharmaceuticals shares slipped 3.2 per cent on Friday, logging an intraday low at Rs 555.65 per share on BSE. The stock dropped after the company posted weak set of Q3 numbers after ...
Akums Drugs and Pharmaceuticals on Friday reported a 15% rise in adjusted profit to Rs 66.3 crore in the quarter ended Dec. 31, 2024. The company had posted an adjusted profit of Rs 57.5 crore in the ...
Akums saw a 15% year-over-year rise in adjusted profit after tax (PAT), attributed to a refined product mix and improved profitability within the CDMO scope. Notably, the company achieved a reduction ...
J&K Leather Goods Industry: Vast Potential & Training Opportunities Union minister highlights vast potential of J&K's leather goods industry. Training program launched to empower women ...